[Resistant and progressive cutaneous lupus erythematosus treated with belimumab: A retrospective monocentric study].

CONCLUSION: Our study suggests the clinical efficiency of belimumab in a series of 7 patients presenting a resistant and progressive CLE. PMID: 31980188 [PubMed - as supplied by publisher]
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research